Longer Term Data Confirm Subcutaneous Rituximab Efficacy in Follicular Lymphoma

In this video we discuss longer term results of the phase III SABRINA study, which tested the safety and efficacy of subcutaneous rituximab in patients with follicular lymphoma.

Source: CancerNetwork - December 8, 2016 Category: Cancer & Oncology Authors: Andrew Davies, PhD Tags: Conferences/ASH 2016 Street Team Source Type: news